View in EDS HTML Full Text PDF Full Text

Response to Tyrosine Kinase Inhibitors in Real-World Patients With Chronic Myeloid Leukemia.

Saved in:
Bibliographic Details
Title: Response to Tyrosine Kinase Inhibitors in Real-World Patients With Chronic Myeloid Leukemia.
Authors: Szeto AH; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA., Bucci T; Department of Pharmacy, UNC Medical Center, Chapel Hill, NC, USA., Deal A; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA., Zhu A; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA., Ahmad M; Department of Pharmacy, UNC Medical Center, Chapel Hill, NC, USA., Cass AS; Department of Pharmacy, UNC Medical Center, Chapel Hill, NC, USA.; Department of Pharmaceutical Sciences, Vanderbilt University Medical Center, Nashville, TN, USA., Sketch MR; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA., Kemper R; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA., Zeidner JF; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA., Foster MC; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA., Muluneh B; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA.; Department of Pharmacy, UNC Medical Center, Chapel Hill, NC, USA.; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA., Crona DJ; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA.; Department of Pharmacy, UNC Medical Center, Chapel Hill, NC, USA.; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA.
Source: The Annals of pharmacotherapy [Ann Pharmacother] 2022 Jul; Vol. 56 (7), pp. 753-763. Date of Electronic Publication: 2021 Sep 18.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Sage Country of Publication: United States NLM ID: 9203131 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1542-6270 (Electronic) Linking ISSN: 10600280 NLM ISO Abbreviation: Ann Pharmacother Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 34541881
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Response to Tyrosine Kinase Inhibitors in Real-World Patients With Chronic Myeloid Leukemia.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Szeto+AH%22">Szeto AH</searchLink>; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA.<br /><searchLink fieldCode="AU" term="%22Bucci+T%22">Bucci T</searchLink>; Department of Pharmacy, UNC Medical Center, Chapel Hill, NC, USA.<br /><searchLink fieldCode="AU" term="%22Deal+A%22">Deal A</searchLink>; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA.<br /><searchLink fieldCode="AU" term="%22Zhu+A%22">Zhu A</searchLink>; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA.<br /><searchLink fieldCode="AU" term="%22Ahmad+M%22">Ahmad M</searchLink>; Department of Pharmacy, UNC Medical Center, Chapel Hill, NC, USA.<br /><searchLink fieldCode="AU" term="%22Cass+AS%22">Cass AS</searchLink>; Department of Pharmacy, UNC Medical Center, Chapel Hill, NC, USA.; Department of Pharmaceutical Sciences, Vanderbilt University Medical Center, Nashville, TN, USA.<br /><searchLink fieldCode="AU" term="%22Sketch+MR%22">Sketch MR</searchLink>; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA.<br /><searchLink fieldCode="AU" term="%22Kemper+R%22">Kemper R</searchLink>; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA.<br /><searchLink fieldCode="AU" term="%22Zeidner+JF%22">Zeidner JF</searchLink>; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA.<br /><searchLink fieldCode="AU" term="%22Foster+MC%22">Foster MC</searchLink>; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA.<br /><searchLink fieldCode="AU" term="%22Muluneh+B%22">Muluneh B</searchLink>; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA.; Department of Pharmacy, UNC Medical Center, Chapel Hill, NC, USA.; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA.<br /><searchLink fieldCode="AU" term="%22Crona+DJ%22">Crona DJ</searchLink>; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA.; Department of Pharmacy, UNC Medical Center, Chapel Hill, NC, USA.; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229203131%22">The Annals of pharmacotherapy</searchLink> [Ann Pharmacother] 2022 Jul; Vol. 56 (7), pp. 753-763. <i>Date of Electronic Publication: </i>2021 Sep 18.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Sage%22">Sage </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9203131 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1542-6270 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210600280%22">10600280 </searchLink><i>NLM ISO Abbreviation: </i>Ann Pharmacother <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34541881
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1177/10600280211044160
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 753
    Titles:
      – TitleFull: Response to Tyrosine Kinase Inhibitors in Real-World Patients With Chronic Myeloid Leukemia.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Szeto AH
      – PersonEntity:
          Name:
            NameFull: Bucci T
      – PersonEntity:
          Name:
            NameFull: Deal A
      – PersonEntity:
          Name:
            NameFull: Zhu A
      – PersonEntity:
          Name:
            NameFull: Ahmad M
      – PersonEntity:
          Name:
            NameFull: Cass AS
      – PersonEntity:
          Name:
            NameFull: Sketch MR
      – PersonEntity:
          Name:
            NameFull: Kemper R
      – PersonEntity:
          Name:
            NameFull: Zeidner JF
      – PersonEntity:
          Name:
            NameFull: Foster MC
      – PersonEntity:
          Name:
            NameFull: Muluneh B
      – PersonEntity:
          Name:
            NameFull: Crona DJ
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 07
              Text: 2022 Jul
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 1542-6270
          Numbering:
            – Type: volume
              Value: 56
            – Type: issue
              Value: 7
          Titles:
            – TitleFull: The Annals of pharmacotherapy
              Type: main
ResultId 1